Polycystic ovary syndrome is getting a new name because experts say the old one has misled patients and doctors for years.

PCOS is being relabelled polyendocrine metabolic ovarian syndrome, or PMOS, in a move designed to show that the condition reaches far beyond the ovaries. Reports indicate the change comes from a broad push to correct the idea that it is only a gynaecological disorder or simply a condition defined by ovarian cysts. The new label puts the focus on the hormonal and metabolic disruption that often shapes the illness and the care patients need.

The shift from PCOS to PMOS signals a bigger change than branding: experts want diagnosis and treatment to reflect a whole-body condition, not a narrow reproductive label.

The condition can affect many parts of health, and that helps explain why the old name drew criticism. Symptoms may include irregular periods, fertility problems, weight changes, acne, excess hair growth and other signs linked to hormone imbalance, while sources suggest metabolic issues can also play a major role. That mix has long created confusion, especially for people whose symptoms do not match the “cystic ovary” shorthand implied by the name PCOS.

Key Facts

  • PCOS is being renamed polyendocrine metabolic ovarian syndrome, or PMOS.
  • The change aims to show the condition is not only a gynaecological disorder.
  • Symptoms can include menstrual irregularity, fertility issues and signs of hormone imbalance.
  • Treatment typically depends on symptoms and may address both reproductive and metabolic health.

The rename also matters because names shape care. If clinicians and patients think first about cysts and ovaries, they may miss the wider endocrine and metabolic picture. Treatment for the condition has never been one-size-fits-all; care often focuses on symptom management, long-term health risks and fertility goals, depending on the individual. Experts appear to hope that PMOS will push medicine toward earlier recognition and more complete support.

What happens next will determine whether the change carries real weight. Health systems, doctors and patient groups now face the task of updating language, guidance and public understanding. If the new term catches on, it could do more than tidy up a label: it could help millions get faster diagnosis, clearer explanations and treatment that matches the full reality of the condition.